Plato, Munro invest in SpaceX as rival funds wait for the sellers

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

Alex Gluyas

Plato, Munro invest in SpaceX as rival funds wait for the sellers

June 11, 2026
“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.
Read Transcript

Munro Partners and Plato Investment Management are among the few Australian growth funds to invest in Elon Musk’s SpaceX IPO while most of their rivals are sitting back until the world’s hottest stock becomes cheaper.

Nick Griffin, chief investment officer of the $9.1 billion money manager Munro Partners, said he was making a small investment in the rocket company, which is set to hit the boards in New York on Friday (Saturday AEST).

While Griffin acknowledged that SpaceX’s $US1.8 trillion ($2.57 trillion) valuation was expensive, he wanted to ensure that Munro had some exposure should the stock continue to surge well beyond its market debut.

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

The investment chief thinks that opportunity could present itself in a matter of months when insider lock-ups expire and private investors start to cash in.

Musk himself has agreed not to sell any of his roughly 40 per cent stake for at least a year after the IPO.

“If you look at the big IPOs such as Google, Facebook, Uber and even Spotify, there’s so much money that had to come out, so many private investors in SpaceX will have to sell in the next 12 months or two years,” Griffin said. “That private-to-public hand-off usually provides opportunities.”

Plato Investment Management is adopting a similar strategy and is buying shares via the IPO to build a position that will be roughly in line with SpaceX’s weighting on the index.

“[It is] enough to avoid being badly wrong if these businesses do become the next Amazon or Nvidia, but not so much that we’re hostage to a valuation that leaves no room for error,” said David Allen, who runs Plato’s $4.2 billion Global Alpha Fund.

Allen warned that SpaceX was trading on a price to revenue of 100 times, which implied that everything needed to go right for the company, including the technology, competition, regulation and execution.

“When you pay 100 times revenue for a business, you’re not buying a company, you’re buying a specific version of the future,” said the hedge fund manager.

“In our experience, the future has a habit of surprising even the most careful forecasters.”

While Allen has said that SpaceX was likely to make an attractive short in the future – that is when an investor makes money from a stock’s decline – he warned that building a short position now was fraught with risk.

“With a wave of retail money chasing what will likely be a limited free float at IPO, there’s little upside in betting heavily against these on day one,” he said.

While Plato and Munro are dabbling in SpaceX, some fund managers are holding back for now, while others, including Antipodes, are avoiding the company altogether.

A ‘trust me’ story


Alex Pollak, who runs Loftus Peak’s $1.5 billion Global Disruption strategy, said while SpaceX would likely rally in the first few sessions of trading at least, he was still happy to watch from the sidelines.

Pollak pointed to S&P’s decision not to change the rules for a company to join its major indices. That policy contrasted with rivals Nasdaq and FTSE Russell, which recently tweaked their ​requirements.

To join the S&P 500 Index, a company must trade publicly for at least a year, be ‌profitable under US accounting standards and hold a free float of at least 10 per cent. SpaceX meets none of those requirements.

The rocket company posted a net loss of $US4.9 billion last year, while revenue rose 33 per cent ​to $18.6 billion. It has never been profitable.

“The float is clearly oversubscribed and the stock will probably go up, but we’re not investors,” said Pollak.

“To win a place in our portfolio, you need to have the possibility of stock price performance, and risks have to be controlled, but that is not the case with SpaceX because it’s just a ‘trust me’ story.”

Ziller Funds Management has also opted out despite SpaceX ticking many of the boxes required to be eligible for a position in its Ziller Global Fund, including the company being led by its billionaire founder.

Investment chief Joseph Ziller said he was bullish on the space theme, but not on the hefty valuation.

“Reliable launch is in extremely short supply because it’s incredibly difficult to do,” said Ziller.

“The only two players doing it are SpaceX and Rocket Lab, so the supply-constrained nature of the industry means the unit economics are very attractive.”

Ziller held a stake in Rocket Lab but has recently trimmed its position, given the stock has almost quadrupled in value over the past year.

“SpaceX is a similar situation – we’re not so interested at these valuations,” Ziller said. “There will be an opportunity over the next six months to 12 months to get in at a more attractive price.”

Hedge fund manager Jack Hu, who runs the Phoenix Growth Fund, built up a position in SpaceX earlier in the year after taking part in a funding round.

While that stake will be subject to a mandatory lock-up period, Hu has applied for another allocation through the IPO.

If successful, Hu said he planned to sell those shares in the first few days of trading as passive and benchmark-aware investors send the stock soaring.

Munro Partners and Plato Investment Management are among the few Australian growth funds to invest in Elon Musk’s SpaceX IPO while most of their rivals are sitting back until the world’s hottest stock becomes cheaper.

Nick Griffin, chief investment officer of the $9.1 billion money manager Munro Partners, said he was making a small investment in the rocket company, which is set to hit the boards in New York on Friday (Saturday AEST).

While Griffin acknowledged that SpaceX’s $US1.8 trillion ($2.57 trillion) valuation was expensive, he wanted to ensure that Munro had some exposure should the stock continue to surge well beyond its market debut.

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

The investment chief thinks that opportunity could present itself in a matter of months when insider lock-ups expire and private investors start to cash in.

Musk himself has agreed not to sell any of his roughly 40 per cent stake for at least a year after the IPO.

“If you look at the big IPOs such as Google, Facebook, Uber and even Spotify, there’s so much money that had to come out, so many private investors in SpaceX will have to sell in the next 12 months or two years,” Griffin said. “That private-to-public hand-off usually provides opportunities.”

Plato Investment Management is adopting a similar strategy and is buying shares via the IPO to build a position that will be roughly in line with SpaceX’s weighting on the index.

“[It is] enough to avoid being badly wrong if these businesses do become the next Amazon or Nvidia, but not so much that we’re hostage to a valuation that leaves no room for error,” said David Allen, who runs Plato’s $4.2 billion Global Alpha Fund.

Allen warned that SpaceX was trading on a price to revenue of 100 times, which implied that everything needed to go right for the company, including the technology, competition, regulation and execution.

“When you pay 100 times revenue for a business, you’re not buying a company, you’re buying a specific version of the future,” said the hedge fund manager.

“In our experience, the future has a habit of surprising even the most careful forecasters.”

While Allen has said that SpaceX was likely to make an attractive short in the future – that is when an investor makes money from a stock’s decline – he warned that building a short position now was fraught with risk.

“With a wave of retail money chasing what will likely be a limited free float at IPO, there’s little upside in betting heavily against these on day one,” he said.

While Plato and Munro are dabbling in SpaceX, some fund managers are holding back for now, while others, including Antipodes, are avoiding the company altogether.

A ‘trust me’ story


Alex Pollak, who runs Loftus Peak’s $1.5 billion Global Disruption strategy, said while SpaceX would likely rally in the first few sessions of trading at least, he was still happy to watch from the sidelines.

Pollak pointed to S&P’s decision not to change the rules for a company to join its major indices. That policy contrasted with rivals Nasdaq and FTSE Russell, which recently tweaked their ​requirements.

To join the S&P 500 Index, a company must trade publicly for at least a year, be ‌profitable under US accounting standards and hold a free float of at least 10 per cent. SpaceX meets none of those requirements.

The rocket company posted a net loss of $US4.9 billion last year, while revenue rose 33 per cent ​to $18.6 billion. It has never been profitable.

“The float is clearly oversubscribed and the stock will probably go up, but we’re not investors,” said Pollak.

“To win a place in our portfolio, you need to have the possibility of stock price performance, and risks have to be controlled, but that is not the case with SpaceX because it’s just a ‘trust me’ story.”

Ziller Funds Management has also opted out despite SpaceX ticking many of the boxes required to be eligible for a position in its Ziller Global Fund, including the company being led by its billionaire founder.

Investment chief Joseph Ziller said he was bullish on the space theme, but not on the hefty valuation.

“Reliable launch is in extremely short supply because it’s incredibly difficult to do,” said Ziller.

“The only two players doing it are SpaceX and Rocket Lab, so the supply-constrained nature of the industry means the unit economics are very attractive.”

Ziller held a stake in Rocket Lab but has recently trimmed its position, given the stock has almost quadrupled in value over the past year.

“SpaceX is a similar situation – we’re not so interested at these valuations,” Ziller said. “There will be an opportunity over the next six months to 12 months to get in at a more attractive price.”

Hedge fund manager Jack Hu, who runs the Phoenix Growth Fund, built up a position in SpaceX earlier in the year after taking part in a funding round.

While that stake will be subject to a mandatory lock-up period, Hu has applied for another allocation through the IPO.

If successful, Hu said he planned to sell those shares in the first few days of trading as passive and benchmark-aware investors send the stock soaring.

Disclaimer: This material has been prepared by Australian Financial Review, published on June 11, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 7, 2025

On the Couch with Nick Griffin (Munro Partners): Talking AI, Tech and Trump

In this episode, Henry Jennings is joined by Nick Griffin, founding Partner and Chief Investment Officer at Munro Partners (HM1 Core Fund Manager).

Read More
May 5, 2025

Meta and Microsoft surprise, Aussie rate cuts “locked in” & Pimp my Portfolio

Discover the key takeaways on US earnings season—Big Tech, AI and more. Plus, fresh market insights on inflation, potential rate cuts and the latest edition of Pimp my Portfolio.

Read More
April 29, 2025

Three investment sectors offering growth, innovation and opportunity

Magellan’s investment team looks at three interconnected investment sectors that continue to offer growth opportunities.

Read More
May 26, 2025

Less than 5% of stocks are “genuine winners” – here’s how to find them

Interesting story or genuine growth company? "Show me the earnings growth, and I’ll show you what I think about it" says Munro's Qiao Ma.

Read More
Steven Marks presenting at the 2023 Sohn Hearts & Minds Conference in Sydney.Steven Marks presenting at the 2023 Sohn Hearts & Minds Conference in Sydney.Steven Marks presenting at the 2023 Sohn Hearts & Minds Conference in Sydney.Steven Marks presenting at the 2023 Sohn Hearts & Minds Conference in Sydney.
June 27, 2025

Still Obsessed - Steven Marks, Co-Founder and Co-CEO Guzman y Gomez

Discover the next chapter for GYG—what’s changed, what hasn’t, and what Steven’s learned along the way. It’s a candid look at what it takes to lead through hypergrowth without losing the heart of the brand.

Read More
July 1, 2025

Nick Griffin on finding stocks that can double earnings in 5 years

In this episode of Success and More Interesting Stuff, Griffin shares how he built Munro from $20 million to more than $5 billion in FUM, the key signals he looks for in structural winners, and what comes next for AI, healthcare, and defence investing.

Read More
July 22, 2025

The Power of Focus: Running a 20-Stock Global Portfolio

In this episode of Inside the Rope, David Clark is joined by Nikki Thomas, one of Australia's most respected global equity investors and Portfolio Manager at Magellan.

Read More
June 24, 2025

Disruption, Valuation and AI with Alex Pollak of Loftus Peak

Alex Pollak, Chief Investment Officer at Loftus Peak, has built a reputation for investing on the cutting-edge of disruption. And no doubt, US tech has been a good place to invest over the past decade. But a lot of Australian fund managers have invested in that space, few have matched his returns.

Read More
Block is one of HM1's Top Core Holdings recommended by TDM Growth Partners.Block is one of HM1's Top Core Holdings recommended by TDM Growth Partners.Block is one of HM1's Top Core Holdings recommended by TDM Growth Partners.Block is one of HM1's Top Core Holdings recommended by TDM Growth Partners.
September 7, 2025

Block by Block: Building the Future of Money with Owen Jennings

TDM Growth Partners had the pleasure of speaking with Owen Jennings, the product leader of one of the world’s most influential tech companies - Block Inc (NYSE:XYZ).

Read More
October 17, 2025

The Bull Market is Just Getting Started | In the Money with Amber Kanwar

“The best of the bull market is still ahead of us.” That’s how Nick Griffin, Founding Partner and CIO of Munro Partners, sees it. Nick joins In the Money with Amber Kanwar to explain why the AI boom isn’t a bubble — it’s the start of a once-in-a-generation expansion.

Read More
November 4, 2025

Labubu, AI infrastructure & renewable energy: Why China is full of opportunity

It is time we rethink our approach to China? Eric Wong of Stillpoint Investments believes it is time. And between AI, electric vehicles and renewable energy, there are more and more cutting edge industries that China is emerging as a leader.

Read More
December 8, 2025

Stock Story: Nvidia

Munro Partners recently shared a stock story on Nvidia, one of their recommended stocks for HM1's Core Portfolio.

Read More
November 13, 2025

The case for and against an AI bubble

Alan Pullen sits down with Equity Mates to discuss the current market landscape, how investors can navigate an AI-driven environment, and the big question on everyone’s mind: are we in a stock market bubble?

Read More
October 14, 2025

Relevancy and Reinvention – Bruce Buchanan, CEO & Co-Founder, Rokt.

Rokt’s revenue has grown more than eightfold. The company is now strongly profitable and has built on its original insight - the power of relevancy. Tune in for Rokt’s next chapter of growth.

Read More
December 19, 2025

Munro Partners | Wrapping up the year that was and looking to the year ahead

Chief Investment Officer, Nick Griffin of Munro Partners (HM1 Core Fund Manager) reflects on 2025, and outlines how the team are positioning to take on 2026.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.